Prognostic value of epidermal growth factor receptor expression in cervical carcinoma.

199388 citationsJournal Articlebronze Open Access

Authors

R Hale · St. Mary’s Hospital

C. H. Buckley · St. Mary’s Hospital

William J. Gullick · St. Mary’s Hospital

H. Fox · St. Mary’s Hospital

James A. Williams · St. Mary’s Hospital

Frank Wilcox · St. Mary’s Hospital

Abstract

Immunohistochemical demonstration of epidermal growth factor receptor expression may be useful in identifying those patients with a poor prognosis, particularly those with adenosquamous carcinomas which have not metastasised to the regional lymph nodes.

Topics & Keywords

HER2/EGFR in Cancer Research Monoclonal and Polyclonal Antibodies Research Cancer-related gene regulation

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Journal of Clinical Pathology

Volume 46, Issue 2, pp. 149-153

DOI: 10.1136/jcp.46.2.149

Field-Weighted Citation Impact: 1.15